Daniel Janowitz
0009-0003-4090-547X
Publication & Citation Trends
Publications
0 total
Additive value of early-phase β-Amyloid-PET for the differential diagnosis of non-Alzheimer's disease dementia.
Cited by 0
Semantic Scholar
Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment
Cited by 0
Semantic Scholar
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive Aphasia
Cited by 0
Semantic Scholar
Alpha‐synuclein quantitative seed amplification assay predicts conversion to dementia
Cited by 0
Semantic Scholar
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer’s disease
Cited by 0
Semantic Scholar
The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors
Cited by 9
Semantic Scholar
Linking latent trajectories of ageing-related atrophy, white matter hyperintensities, and cognitive ageing over four years: Insights into brain maintenance
Cited by 0
Semantic Scholar
Research Topics
Dementia and Cognitive Impairment Research
(82)
Alzheimer's disease research and treatments
(65)
Functional Brain Connectivity Studies
(47)
Neuroinflammation and Neurodegeneration Mechanisms
(19)
Advanced Neuroimaging Techniques and Applications
(18)
Affiliations
Queen's University Belfast
The University of Texas Health Science Center at San Antonio
Aristotle University of Thessaloniki
Florey Institute of Neuroscience and Mental Health
German Center for Neurodegenerative Diseases